OUTLOOK THERAPEUTICS, INC. Revenues
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Revenues of $8.15 million for the 12-month period ending 2019-09-30, per its 10-K filed 2020-12-23.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2020-12-23
- OUTLOOK THERAPEUTICS, INC. revenues for the quarter ending 2019-09-30 was $5.85M, a 658.34% increase year-over-year.
- OUTLOOK THERAPEUTICS, INC. revenues for the quarter ending 2019-06-30 was $583.85K, a 24.36% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. revenues for the quarter ending 2019-03-31 was $641.14K, a 16.94% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. revenues for the quarter ending 2018-12-31 was $1.07M, a 38.31% increase year-over-year.
- OUTLOOK THERAPEUTICS, INC. revenues for fiscal 2019 was $8.15M, a 163.84% increase from fiscal 2018.
- OUTLOOK THERAPEUTICS, INC. revenues for fiscal 2018 was $3.09M, a 18.99% decline from fiscal 2017.
- OUTLOOK THERAPEUTICS, INC. revenues for fiscal 2017 was $3.81M, a 27.92% increase from fiscal 2016.
- OUTLOOK THERAPEUTICS, INC. revenues for fiscal 2016 was $2.98M, a 42.91% decline from fiscal 2015.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|---|
| 2019-09-30 | $5.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-23 | $6.44M derived: sum of 2 quarters · filed 2020-12-23 | $7.08M derived: sum of 3 quarters · filed 2020-12-23 | $8.15M 10-K · filed 2020-12-23 | |
| 2019-06-30 | $583.85K 10-Q · filed 2020-08-14 | $1.22M derived: sum of 2 quarters · filed 2020-08-14 | $2.29M 10-Q · filed 2020-08-14 | $3.06M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $641.14K 10-Q · filed 2020-05-15 | $1.71M 10-Q · filed 2020-05-15 | $2.48M derived: sum of 3 quarters · filed 2020-05-15 | $3.25M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $1.07M 10-Q · filed 2020-02-14 | $1.84M derived: sum of 2 quarters · filed 2020-02-14 | $2.61M derived: sum of 3 quarters · filed 2020-02-14 | $3.38M derived: sum of 4 quarters · filed 2020-02-14 | |
| 2018-09-30 | $771.89K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-19 | $1.54M derived: sum of 2 quarters · filed 2019-12-19 | $2.32M derived: sum of 3 quarters · filed 2019-12-19 | $3.09M 10-K · filed 2019-12-19 | |
| 2018-06-30 | $771.89K 10-Q · filed 2019-08-14 | $1.54M derived: sum of 2 quarters · filed 2019-08-14 | $2.32M 10-Q · filed 2019-08-14 | $5.22M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $771.89K 10-Q · filed 2019-05-15 | $1.54M 10-Q · filed 2019-05-15 | $4.45M derived: sum of 3 quarters · filed 2019-05-15 | $4.75M derived: sum of 4 quarters · filed 2019-05-15 | |
| 2017-12-31 | $771.89K 10-Q · filed 2019-02-14 | $3.67M derived: sum of 2 quarters · filed 2019-02-14 | $3.98M derived: sum of 3 quarters · filed 2019-02-14 | $4.28M derived: sum of 4 quarters · filed 2019-02-14 | |
| 2017-09-30 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-18 | $3.21M derived: sum of 2 quarters · filed 2018-12-18 | $3.51M derived: sum of 3 quarters · filed 2018-12-18 | $3.81M 10-K · filed 2018-12-18 | |
| 2017-06-30 | $303.14K 10-Q · filed 2018-08-14 | $606.28K derived: sum of 2 quarters · filed 2018-08-14 | $909.42K 10-Q · filed 2018-08-14 | $1.40M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $303.14K 10-Q · filed 2018-05-15 | $303.14K 10-Q · filed 2017-05-15 | $606.28K 10-Q · filed 2018-05-15 | $1.10M derived: sum of 3 quarters · filed 2018-05-15 | $1.60M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $303.14K 10-Q · filed 2018-02-14 | $798.03K derived: sum of 2 quarters · filed 2018-02-14 | $1.29M derived: sum of 3 quarters · filed 2018-02-14 | $2.29M derived: sum of 4 quarters · filed 2018-02-14 | |
| 2016-09-30 | $494.89K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-29 | $989.79K derived: sum of 2 quarters · filed 2017-12-29 | $1.98M derived: sum of 3 quarters · filed 2017-12-29 | $2.98M 10-K · filed 2017-12-29 | |
| 2016-06-30 | $494.89K 10-Q · filed 2017-08-14 | $1.49M derived: sum of 2 quarters · filed 2017-08-14 | $2.48M 10-Q · filed 2017-08-14 | $2.98M derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | $994.89K 10-Q · filed 2017-05-15 | $1.99M 10-Q · filed 2017-05-15 | $2.48M derived: sum of 3 quarters · filed 2017-05-15 | $3.78M derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | $994.89K 10-Q · filed 2017-02-14 | $1.49M derived: sum of 2 quarters · filed 2017-02-14 | $2.78M derived: sum of 3 quarters · filed 2017-02-14 | $3.28M derived: sum of 4 quarters · filed 2017-02-14 | |
| 2015-09-30 | $494.89K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-29 | $1.79M derived: sum of 2 quarters · filed 2016-12-29 | $2.28M derived: sum of 3 quarters · filed 2016-12-29 | $5.22M 10-K · filed 2016-12-29 | |
| 2015-06-30 | $1.29M 10-Q · filed 2016-08-15 | $1.79M derived: sum of 2 quarters · filed 2016-08-15 | $4.72M 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $494.89K 10-Q · filed 2016-06-27 | $3.43M 10-Q · filed 2016-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |